1.Changes of molecular markers in cultured skin stem cells exposed to ultraviolet B (UVB) in vitro
Chinese Journal of Dermatology 2010;43(10):726-729
Objective To investigate the changes of molecular markers in cultured skin stem cells exposed to UVB in vitro. Methods Skin stem cells were isolated and cultured according to their adherasion ability,and identified by immunohistochemistry using anti-K15 and anti-β-integrin antibodies. Then, a part of the skin stem cells were irradiated with UVB at 10 mJ/cm2 for 2 times. After 24-hour additional culture, the expressions of CD34, beta-catenin and p53 were detected with immunohistochemistry. Results Skin stem cells showed a high density in culture free of irradiation, which were round or polygon with a clear shape, well-distributed cytoplasm, high N/C ratio; mitotic cells could be seen. In unirradiated skin stem cells, beta-catenin was expressed predominantly in cell membrane and cytoplasm, with a positive expression rate of 64.74% and 8.4%in membrane and cytoplasm respectively; p53 was expressed mainly in cell cytoplasm and nuclei, with a positive expression rate of 6.9% in cell nuclei. After exposure to UVB, skin stem cells decreased in cell density and N/C ratios with a deformed and anomalous shape, vacuoles were present in cytoplasm, and some cells experienced karyopyknosis or apoptosis. Additionally, in irradiated cells, beta-catenin was expressed predominantly in cytoplasm with a positive expression rate of 64.74% and 0 in cytoplasm and nuclei, respectively; p53 was expressed mainly in nuclei with a positive expression rate of 100%. CD34 was detected in neither unirradiated nor irradiated skin stem cells. Conclusion UVB can promote beta-eatenin to accumulate in cytoplasm as well as beta-catenin and p53 to migrate from cytoplasm to nuclei.
2.Impact of hyperglycemia on prognosis for patients admitted to medical intensive care units
Chinese Journal of General Practitioners 2009;8(5):312-315
ObjectiveTo evaluate the impact of hyperglycemia in patients admitted to medical intensive care units(MICU)on their prognosis.MethodsMedical records of 1016 patients,including 126 cases of known diabetes,359 cases with newly diagnoses hyperglycemia,and 531 normoglycemic cases,admitted to MICU in Wuhan University People's Hospital during September 2006 to September 2007 were reviewed to compare their case-fatality,length of hospital stay,length of MICU stay,mechanical ventilation,blood transfusion and antibiotics use.ResultsIn.hospital case-fatality was 22.8%(82/359)in patients with newly-diagnosed hyperglycemia.significantly higher than that in patients with known diabetes of 12.7% (16/126)and in normoglyeemic cases of 5.1%(27/531)(P<0.01),and that Was higher in those with diabetes than those with normal blood glucose level(P=0.002).Proportions of patients who needed mechanical ventilation,blood transfusion,antibiotics use was higher in newly diagnosed hyperglycemia group than those in the other two groups.ConclusionsHyperglycemia represents an important mal'ker of poor clinical outcomes and mortality in patients admitted tO MICU.Patients with newly diagnosed hyperglycemia had a significantly higher case-fatality and poorer outcomes than those with known diabetes or normoglyeemia.
3.Clinical Study on Xianglian Mixture in Treatment of Premature Beat Accompanied Anxiety Disorder
Journal of Traditional Chinese Medicine 1992;0(12):-
Objective To study the clinical effect of Xianglian in Mixture (Mixture of Nutgrass Galingale Rhizome and Golden Thread) in treatment of premature beat accompanied anxiety disorder.Methods Totally 100 patients of premature beat accompanied anxiety disorder were randomly assigned into two groups.The 50 patients in the treatment group were treated with Xianglian Mixture and the 50 in the control group were treated with Rytmonorm and Alprazolam for 4 weeks.The TCM symptom scores,premature beats in Holter,scores of Hamilton anxiety scale (HAMA) and the therapeutic effect on all these indices of both groups were observed.Results After treatment,the TCM symptom scores,premature beats in Holter,scores of HAMA of both groups were decreased significantly (P0.05).Conclusion Xianglian Mixture can reduce premature beats and relieve anxiety as well.
4.Common clinical types and management of secondary glaucoma after ocular trauma
Jing, REN ; Jing-Wen, LIU ; Bo, QIN
International Eye Science 2016;16(6):1071-1075
?Ocular trauma related glaucoma is one of secondary glaucoma, which can lead to serious visual loss. According to the complex clinical findings and pathogenesis of ocular trauma related glaucoma, we divide traumatic secondary glaucoma into hyphema related glaucoma, angle recession related, lens injury related, adhesion and proliferation related. The treatment of secondary traumatic glaucoma with ocular trauma were different, specific treatment measures should be given according to the specific case to protect visual function.
5.Fibroblastic reticular cell tumor: report of a case.
Chinese Journal of Pathology 2011;40(8):563-564
Abdominal Neoplasms
;
metabolism
;
pathology
;
Adolescent
;
Diagnosis, Differential
;
Fibroblasts
;
metabolism
;
pathology
;
Groin
;
Histiocytoma, Malignant Fibrous
;
metabolism
;
pathology
;
Humans
;
Keratins
;
metabolism
;
Lymph Nodes
;
metabolism
;
pathology
;
Lymphoma
;
metabolism
;
pathology
;
Male
;
Melanoma
;
metabolism
;
pathology
;
Vimentin
;
metabolism
6.A new target in non-small cell lung cancer: ROS1 fusion gene.
Chinese Journal of Oncology 2013;35(1):1-4
Antigens, Differentiation, B-Lymphocyte
;
genetics
;
Carcinoma, Non-Small-Cell Lung
;
drug therapy
;
genetics
;
metabolism
;
Gene Fusion
;
Gene Rearrangement
;
Histocompatibility Antigens Class II
;
genetics
;
Humans
;
Immunohistochemistry
;
In Situ Hybridization, Fluorescence
;
Lung Neoplasms
;
drug therapy
;
genetics
;
metabolism
;
Protein Kinase Inhibitors
;
therapeutic use
;
Protein-Tyrosine Kinases
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Proto-Oncogene Proteins
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Pyrazoles
;
therapeutic use
;
Pyridines
;
therapeutic use
;
Reverse Transcriptase Polymerase Chain Reaction
;
Signal Transduction
;
Sodium-Phosphate Cotransporter Proteins, Type IIb
;
genetics
7.Ca2+]i homeostasis and caspase-3 gene expression in verapamil-induced retinal pigment epithelium cells apoptosis in vit
International Eye Science 2011;11(1):1-3
(Ver)-induced human retinal pigment epithelium (RPE) cells apoptosis.hours to induce RPE cells apoptosis.The expression of apoptotic effector gene caspase-3 was assessed by reverse transcription polymerase chain reaction (RT-PCR).Single cell was measured using fluorescence indicator Fura-3/AM with MetaFluo4.5/coolsnapfx/IX70 intracellular Ca2+ fluorescence imaging system.RPE cells and it significantly increased after co-cultured with Ver.The fluorescence in resting RPE cells was strong and distributed throughout the cells.The nucleus appeared more fluorescent than the cytoplasm.Calcium fluorescence of RPE cells attenuated after co-cultured with Ver.[Ca2+]i homeostasis might play pivotal roles in Ver-induced RPE cells apoptosis.
8.Research progress of the association between PAX6 gene and retinal diseases
International Eye Science 2014;(9):1606-1607
PAX6 gene plays an important role in embryological development, and the mutation of this gene may result incongenital aniridia, retinoblastoma, macula hypoplasia, Peters' anomaly and so on. A brief introduction of the background PAX6 gene, and the association between PAX6 and retinal diseases were summarized in this review.
9.Treatment for traumatic optic neuropathy with mouse nerve growth factor:a meta-analysis
International Eye Science 2015;(4):633-635
AIM:To evaluate the efficacy of treating traumatic optic neuropathy( TON) with mouse nerve growth factor.
METHODS: We searched the Cochrane Library, Pubmed, Medline, CNKI, Wanfang database and VIP to collect randomized controlled trials ( RCTs ) of using mouse nerve growth factor for TON. The quality of the included trials was assessed and poor-qualified trials were eliminated before the meta - analysis was conducted.
RESULTS:Seven RCTs with a total of 399 eyes included were retrieved, and OR=3. 78 with a 95%CI of [ 2. 35, 6.06], the difference was significant (P<0. 01).
CONCLUSION:The existing evidence supports that the prognosis of TON is better when mouse nerve growth factor are adopted in treatment, but there is still a need for well-planned, large-scale and multicenter RCTs to verify it.
10.Effects of different antidiabetic therapies on the macular thickness in diabetes patients without fundus complication
International Eye Science 2016;16(8):1541-1542
Abstract?AIM: To observe the effects of different antidiabetic therapies on macular thickness in diabetes patients without fundus complication.?METHODS: The macular thickness was measured by optical coherence tomography ( OCT) .The retina volume on the center of macula was scanned, and it generated automatically the average thickness data of three rings and nine areas of 1mm, 3mm and 6mm.The data were statistically analyzed.?RESULTS: Healthy control group, oral hypoglycemic drug group and insulin treatment group were enrolled. Each group included 22 cases 22 eyes.The macular retinal thickness of healthy control group is 268.09±17.97μm (the 1st ring), 340.41 ±22.25μm ( the 2nd ring) and 298.14 ± 12.90μm ( the 3 rd ring ) , respectively. The macular thickness of oral hypoglycemic drug group is 260.00 ± 18.17μm (the 1st ring), 335.44±21.12μm (the 2nd ring) and 295.63 ±15.92μm ( the 3rd ring), respectively.The macular thickness of insulin therapy group is 271.01 ± 26.09μm (the 1st ring), 340.86±17.10μm (the 2nd ring) and 298.57 ±12.14μm ( the 3rd ring ), respectively. Comparison of the macular thickness of the 1st ring among 3 groups was insignificant (F=1.21, P=0.31), neither the comparison of the 2nd ring (F=0.35, P=0.71), neither the comparison of the 3rd ring (F=0.22, P=0.81).? CONCLUSION: Compared with healthy individuals, both oral antidiabetic medicines and insulin therapy don't alter the macular thickness of patients with diabetes while without fundus complication.